ConductScience.org, home

Paper41533467

Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy.

Munoz Mendoza J and 11 others. Clin J Am Soc Nephrol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy. Papers, record 41533467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41533467

Download JSON
Disease
type 2 diabetes mellitus613 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy.
PubMed
Journal
Clin J Am Soc Nephrol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-20
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Munoz Mendoza JJairhttps://orcid.org/0009-0006-0669-6055
2Weir MRMatthew Rhttps://orcid.org/0000-0001-8820-5702
3Anker SDStefan D
4Filippatos GGerasimoshttps://orcid.org/0000-0002-5640-0332
5Rossing PPeterhttps://orcid.org/0000-0002-1531-4294
6Ahlers CChristiane
7Brinker MMeikehttps://orcid.org/0000-0002-1560-9535
8Fatoba STSamuel T
9Horvat-Broecker AAndrea
10Rohwedder KKatja
11Fornoni AAlessiahttps://orcid.org/0000-0002-1313-7773
12FIDELIO-DKD and FIGARO-DKD InvestigatorsGroup

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NephrectomyMajor topic
Diabetes Mellitus, Type 2Major topic
Renal Insufficiency, ChronicMajor topic
AlbuminuriaMajor topic
NaphthyridinesMajor topic
Mineralocorticoid Receptor AntagonistsMajor topic
Diabetic NephropathiesMajor topic
Humans
Female
Male
Disease Progression
Middle Aged
Aged
Treatment Outcome
Hyperkalemia

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Bayer AGPubMed

Source PubMed

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02540993Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseDerived from the trialYesClinicalTrials.gov
NCT02545049Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseDerived from the trialYesClinicalTrials.gov

Download CSV of trials

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127018509Proteinuria is a Predictor of Renal Functional Decline in Patients with Kidney Cancer.J Urol2016https://conductscience.org/library/papers/27018509PubMed
238788900Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.Ann Oncol2024https://conductscience.org/library/papers/38788900PubMed
324704019Prospective measurement of urinary microalbumin in living kidney donor nephrectomy: toward understanding the renal functional recovery period.J Urol2014https://conductscience.org/library/papers/24704019PubMed
428926607The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury.PLoS One2017https://conductscience.org/library/papers/28926607PubMed
525824808Nephrectomy for benign disease in the UK: results from the British Association of Urological Surgeons nephrectomy database.BJU Int2016https://conductscience.org/library/papers/25824808PubMed
627798198Radical versus partial nephrectomy, chronic kidney disease progression and mortality in US veterans.Nephrol Dial Transplant2018https://conductscience.org/library/papers/27798198PubMed
734599260Critical timing of ACEi initiation prevents compensatory glomerular hypertrophy in the remaining single kidney.Sci Rep2021https://conductscience.org/library/papers/34599260PubMed
837394174A Predictive Model for Kidney Failure After Nephrectomy for Localized Kidney Cancer: The Kidney Cancer Risk Equation.Am J Kidney Dis2023https://conductscience.org/library/papers/37394174PubMed
931665733Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.Am J Nephrol2019https://conductscience.org/library/papers/31665733PubMed
1024621652Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury.J Cardiovasc Pharmacol2014https://conductscience.org/library/papers/24621652PubMed
1131935154Proteinuria as an independent predictor of stroke: Systematic review and meta-analysis.Int J Stroke2020https://conductscience.org/library/papers/31935154PubMed
1218337713Long-term outcomes in nondiabetic chronic kidney disease.Kidney Int2008https://conductscience.org/library/papers/18337713PubMed
1338048573Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.Ann Intern Med2023https://conductscience.org/library/papers/38048573PubMed
1429018140Incident CKD after Radical or Partial Nephrectomy.J Am Soc Nephrol2018https://conductscience.org/library/papers/29018140PubMed
1530635226Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.Lancet Diabetes Endocrinol2019https://conductscience.org/library/papers/30635226PubMed
1625784968Impact of microalbuminuria on incident coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis of prospective studies.Int J Clin Exp Med2015https://conductscience.org/library/papers/25784968PubMed
1711373357Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation.J Am Soc Nephrol2001https://conductscience.org/library/papers/11373357PubMed
1835023547Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.Eur Heart J2022https://conductscience.org/library/papers/35023547PubMed
1924747655Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival.J Urol2014https://conductscience.org/library/papers/24747655PubMed
2011696703Renal outcome 25 years after donor nephrectomy.J Urol2001https://conductscience.org/library/papers/11696703PubMed

See all 48 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
FINERENONECHEMBL2181927Derived from the trial2https://conductscience.org/library/drugs/CHEMBL2181927

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Cited by
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41533467

GET https://conductscience.org/api/papers/v1/41533467/references?page=2